| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |



*Tulane University School of Medicine and
School of Public Health and Tropical Medicine, New Orleans, Louisiana.
Correspondence to Dr. Jiang He, Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1430 Tulane Avenue SL18. Phone: 504-588-5165; Fax: 504-988-1568;
ABSTRACT. This study examined the relationship of fasting serum glucose, insulin, C-peptide, glycosylated hemoglobin A (HbA1c), and Homeostasis Model Assessment (HOMA)-insulin resistance to risk of chronic kidney disease (CKD) among 6453 persons without diabetes (fasting glucose <126 mg/dl and not taking diabetes medication) who participated in the Third National Health and Nutrition Examination Survey and were aged 20 yr or older. CKD was defined as an estimated GFR <60 ml/min per 1.73 m2. The prevalence of CKD was significantly and progressively higher with increasing levels of serum insulin, C-peptide, HbA1c, and HOMA-insulin resistance. After adjustment for potential confounding variables, the odds ratio of CKD for the highest compared with the lowest quartile was 4.03 (95% confidence interval [CI], 1.81 to 8.95; P = 0.001), 11.4 (95% CI, 4.07 to 32.1; P < 0.001), 2.67 (95% CI, 1.31 to 5.46; P = 0.002), and 2.65 (95% CI, 1.25 to 5.62; P = 0.008) for serum insulin, C-peptide, HbA1c levels, and HOMA-insulin resistance, respectively. For a one SD higher level of serum insulin (7.14 µU/ml), C-peptide (0.45
mol/ml), HbA1c (0.52%), and HOMA-insulin resistance (1.93), the odds ratio (95% CI) of CKD was 1.35 (1.16 to 1.57), 2.78 (2.25 to 3.42), 1.69 (1.28 to 2.23), and 1.30 (1.13 to 1.50), respectively. These findings combined with knowledge from previous studies suggest that the insulin resistance and concomitant hyperinsulinemia are presented in CKD patients without clinical diabetes. Further studies into the causality between insulin resistance and CKD are warranted. E-mail address: jhe@tulane.edu
This article has been cited by other articles:
![]() |
S. Kobayashi, M. Oka, K. Maesato, R. Ikee, T. Mano, M. Hidekazu, and T. Ohtake Coronary Artery Calcification, ADMA, and Insulin Resistance in CKD Patients Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1289 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nerpin, U. Riserus, E. Ingelsson, J. Sundstrom, M. Jobs, A. Larsson, S. Basu, and J. Arnlov Insulin Sensitivity Measured With Euglycemic Clamp Is Independently Associated With Glomerular Filtration Rate in a Community-Based Cohort Diabetes Care, August 1, 2008; 31(8): 1550 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shankar, C. Leng, K. S. Chia, D. Koh, E. S. Tai, S. M. Saw, S. C. Lim, and T. Y. Wong Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1910 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kanauchi, K. Kanauchi, T. Inoue, K. Kimura, and Y. Saito Insulin sensitivity and beta-cell function in older Japanese adults without diabetes Age Ageing, May 1, 2008; 37(3): 330 - 333. [Full Text] [PDF] |
||||
![]() |
C. Lorenzo, S. D. Nath, A. J.G. Hanley, H. E. Abboud, and S. M. Haffner Relation of Low Glomerular Filtration Rate to Metabolic Disorders in Individuals without Diabetes and with Normoalbuminuria Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 783 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Choi and E. S. Ford Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey Rheumatology, May 1, 2008; 47(5): 713 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
M L. Trirogoff, A. Shintani, J. Himmelfarb, and T A. Ikizler Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3 4 chronic kidney disease patients Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1642 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Whaley-Connell, B. S. Pavey, K. Chaudhary, G. Saab, and J. R. Sowers Review: Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 27 - 35. [Abstract] [PDF] |
||||
![]() |
A. Rashidi, A. Ghanbarian, and F. Azizi Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 976 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ritz Metabolic Syndrome: An Emerging Threat to Renal Function Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 869 - 871. [Full Text] [PDF] |
||||
![]() |
M. F. Crutchlow, B. Robinson, B. Pappachen, N. Wimmer, A. J. Cucchiara, D. Cohen, and R. Townsend Validation of Steady-State Insulin Sensitivity Indices in Chronic Kidney Disease Diabetes Care, July 1, 2007; 30(7): 1813 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Oterdoom, A. P. J. de Vries, R. T. Gansevoort, P. E. de Jong, R. O. B. Gans, S. J. L. Bakker, and for the PREVEND Study Group Fasting insulin modifies the relation between age and renal function Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1587 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Wahba and R. H. Mak Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 550 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kaartinen, J. Syrjanen, I. Porsti, A. Harmoinen, A. Pasternack, H. Huhtala, O. Niemela, and J. Mustonen Insulin resistance and the progression of IgA glomerulonephritis Nephrol. Dial. Transplant., March 1, 2007; 22(3): 778 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Perlstein, M. Gerhard-Herman, N. K. Hollenberg, G. H. Williams, and A. Thomas Insulin Induces Renal Vasodilation, Increases Plasma Renin Activity, and Sensitizes the Renal Vasculature to Angiotensin Receptor Blockade in Healthy Subjects J. Am. Soc. Nephrol., March 1, 2007; 18(3): 944 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ryu, Y. Chang, D.-I. Kim, W. S. Kim, and B.-S. Suh {gamma}-Glutamyltransferase as a Predictor of Chronic Kidney Disease in Nonhypertensive and Nondiabetic Korean Men Clin. Chem., January 1, 2007; 53(1): 71 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kanauchi, K. Kanauchi, K. Kimura, T. Inoue, and Y. Saito Associations of chronic kidney disease with the metabolic syndrome in non-diabetic elderly Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3608 - 3609. [Full Text] [PDF] |
||||
![]() |
S. G. de Vinuesa, M. Goicoechea, J. Kanter, M. Puerta, V. Cachofeiro, V. Lahera, F. Gomez-Campdera, and J. Luno Insulin Resistance, Inflammatory Biomarkers, and Adipokines in Patients with Chronic Kidney Disease: Effects of Angiotensin II Blockade J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S206 - S212. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Fried, R. Katz, M. J. Sarnak, M. G. Shlipak, P. H.M. Chaves, N. S. Jenny, C. Stehman-Breen, D. Gillen, A. J. Bleyer, C. Hirsch, et al. Kidney Function as a Predictor of Noncardiovascular Mortality J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3728 - 3735. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Fox, M. G. Larson, E. P. Leip, J. B. Meigs, P. W.F. Wilson, and D. Levy Glycemic Status and Development of Kidney Disease: The Framingham Heart Study Diabetes Care, October 1, 2005; 28(10): 2436 - 2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kramer and M. E. Molitch Screening for Kidney Disease in Adults With Diabetes Diabetes Care, July 1, 2005; 28(7): 1813 - 1816. [Full Text] [PDF] |
||||
![]() |
M. Kurella, J. C. Lo, and G. M. Chertow Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2134 - 2140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Sedor and J. R. Schelling Association of Metabolic Syndrome in Nondiabetic Patients with Increased Risk for Chronic Kidney Disease: The Fat Lady Sings J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1880 - 1882. [Full Text] [PDF] |
||||
![]() |
B. Becker, F. Kronenberg, J. T. Kielstein, H. Haller, C. Morath, E. Ritz, D. Fliser, and for the MMKD Study Group Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease: The Mild and Moderate Kidney Disease Study J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1091 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lau, P.-O. Carlsson, P.S. Leung, C. Wolfrum, E. Asilmaz, E. Luca, J.M. Friedman, M. Stoffel, J.C. Verhave, H.L. Hillege, et al. Why Less Diabetes with Blockade of the Renin-Angiotensin System?: Evidence for a Local Angiotensin-Generating System and Dose-Dependent Inhibition of Glucose-Stimulated Insulin Release by Angiotensin II in Isolated Pancreatic Islets. Diabetologia 47: 240-248, 2004 J. Am. Soc. Nephrol., March 1, 2005; 16(3): 567 - 573. [Full Text] [PDF] |
||||
![]() |
S. P. Bagby Obesity-Initiated Metabolic Syndrome and the Kidney: A Recipe for Chronic Kidney Disease? J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2775 - 2791. [Full Text] [PDF] |
||||
![]() |
J. Chen, P. Muntner, L. L. Hamm, D. W. Jones, V. Batuman, V. Fonseca, P. K. Whelton, and J. He The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults Ann Intern Med, February 3, 2004; 140(3): 167 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Ritz Minor renal dysfunction: an emerging independent cardiovascular risk factor Heart, September 1, 2003; 89(9): 963 - 964. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673